Lifelong Aids Alliance – Trademark Portfolio

Entity Type: 99

Lifelong Aids Alliance holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include LIFELONG. The owner is based in Seattle, WA.

127 Broadway Ave. E.

Seattle, WA 981025786

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LIFELONG
LIFELONG
Registered 2001

Trademark Classifications

Lifelong Aids Alliance's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

36
Insurance & Financial (1 filing)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does Lifelong Aids Alliance have?

Lifelong Aids Alliance has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Lifelong Aids Alliance file in?

Lifelong Aids Alliance files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 36 (Insurance & Financial). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Lifelong Aids Alliance's most well-known trademarks?

Lifelong Aids Alliance's registered trademark portfolio includes well-known marks such as LIFELONG. These are among 1 currently registered trademark in the portfolio.

What is Lifelong Aids Alliance's trademark registration success rate?

Lifelong Aids Alliance has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.